The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Management of hepatitis B: Summary of a clinical research workshop†
Open accessAbstract
Chronic hepatitis B is caused by persistent infection with the hepatitis B virus (HBV), a unique DNA virus that replicates through an RNA intermediate produced from a stable covalently closed circular DNA molecule. Viral persistence appears to be due to inadequate innate and adaptive immune responses. Chronic infection has a variable course after several decades resulting in cirrhosis in up to one-third of patients and liver cancer in a proportion of those with cirrhosis. Sensitive assays for HBV DNA levels in serum have been developed that provide important insights into pathogenesis and natural history. Therapy of hepatitis B is evolving. Peginterferon induces long-term remissions in disease in one-third of patients with typical hepatitis B e antigen (HBeAg) positive chronic hepatitis B, but a lesser proportion of those without HBeAg. Several oral nucleoside analogues with activity against HBV have been shown to be effective in suppressing viral levels and improving biochemical and histological features of disease in a high proportion of patients with and without HBeAg, at least in the short term. What is uncertain is which agent or combination of agents is most effective, how long therapy should last, and which criteria should be used to start, continue, switch or stop therapy. Long-term therapy with nucleoside analogues may be the most appropriate approach to treatment, but the expense and lack of data on long-term safety and efficacy make recommendations difficult. Clearly, many basic and clinical research challenges remain in defining optimal means of management of chronic hepatitis B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Self-citationClassification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Self-citationSampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
A One-Year Trial of Lamivudine for Chronic Hepatitis B
Lai, C.-L., Chien, R.-N., Leung, N. W. Y., Chang, T.-T., Guan, R., Tai, D.-I., Ng, K.-Y., Wu, P.-C., Dent, J. C., Barber, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390201 · Cited by 1,754
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
Chang, T.-T., Gish, R. G., de Man, R., Gadano, A., Sollano, J., Chao, Y.-C., Lok, A. S., Han, K.-H., Goodman, Z., Zhu, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051285 · Cited by 1,444
Self-citationAdefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
Marcellin, P., Chang, T.-T., Lim, S. G., Tong, M. J., Sievert, W., Shiffman, M. L., Jeffers, L., Goodman, Z., Wulfsohn, M. S., Xiong, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020681 · Cited by 1,336
Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States
Dienstag, J. L., Schiff, E. R., Wright, T. L., Perrillo, R. P., Hann, H.-W. L., Goodman, Z., Crowther, L., Condreay, L. D., Woessner, M., Rubin, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411702 · Cited by 1,226
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Lai, C.-L., Shouval, D., Lok, A. S., Chang, T.-T., Cheinquer, H., Goodman, Z., DeHertogh, D., Wilber, R., Zink, R. C., Cross, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051287 · Cited by 1,188
Self-citationJanssen, H. L., van Zonneveld, M., Senturk, H., Zeuzem, S., Akarca, U. S., Cakaloglu, Y., Simon, C., So, T. M., Gerken, G., de Man, R. A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17701-0 · Cited by 1,162
Marcellin, P., Lau, G. K. K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.-M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040431 · Cited by 1,145
LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES
Ules, J., Ienstag, L. D., Chiff, E. U. R. S., Right, L. W., Errillo, R. O. P. P., Ann, L. H., Rowther, L. Y. C., Ondreay, D. C., Oessner, M. A. W., Ubin, M. A. R., et al. (1999) · Cited by 1,116
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T.-T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Wulfsohn, M. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021812 · Cited by 995
Wong, D. K. H., Cheung, A. M., O'Rourke, K., Naylor, C. D., Detsky, A. S., & Heathcote, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00011 · Cited by 984
Bica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., & Snydman, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/318501 · Cited by 974
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Kao, J., Chen, P., Lai, M., & Chen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70261-7 · Cited by 925
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Self-citationLong-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
Maini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1269 · Cited by 800
Management of hepatitis B: 2000—Summary of a workshop
Lok, A. S., Heathcote, E. J., & Hoofnagle, J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.24839 · Cited by 776
Self-citationSide effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1053/jhep.2002.36810 · Cited by 727
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, Y.-S., Chien, R.-N., Yeh, C.-T., Sheen, I.-S., Chiou, H.-Y., Chu, C.-M., & Liaw, Y.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.33638 · Cited by 705
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
Liaw, Y., Leung, N. W. Y., Chang, T., Guan, R., Tai, D., Ng, K., Chien, R., Dent, J., Roman, L., Edmundson, S., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.8559 · Cited by 689
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., & Chen, T.-J. (1988) · Hepatology · doi:10.1002/hep.1840080310 · Cited by 612
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
Angus, P., Vaughan, R., Xiong, S., Yang, H., Delaney, W., Gibbs, C., Brosgart, C., Colledge, D., Edwards, R., Ayres, A., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00939-9 · Cited by 564
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Peters, M. G., Hann, H. W., Martin, P., Heathcote, E. J., Buggisch, P., Rubin, R., Bourliere, M., Kowdley, K., Trepo, C., Gray, D. F., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.051 · Cited by 552
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T.-T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Ma, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042957 · Cited by 531
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
Deres, K., Schröder, C. H., Paessens, A., Goldmann, S., Hacker, H. J., Weber, O., Krämer, T., Niewöhner, U., Pleiss, U., Stoltefuss, J., et al. (2003) · Science · doi:10.1126/science.1077215 · Cited by 508
Markowitz, J. S., Martin, P., Conrad, A. J., Markmann, J. F., Seu, P., Yersiz, H., Goss, J. A., Schmidt, P., Pakrasi, A., Artinian, L., et al. (1998) · Hepatology · doi:10.1002/hep.510280241 · Cited by 485
Cooksley, W. G. E., Piratvisuth, T., Lee, S. ‐., Mahachai, V., Chao, Y. ‐., Tanwandee, T., Chutaputti, A., Chang, W. Y., Zahm, F. E., & Pluck, N. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00450.x · Cited by 475
Esteve, M., Saro, C., González-Huix, F., Suarez, F., Forné, M., & Viver, J. M. (2004) · Gut · doi:10.1136/gut.2004.040675 · Cited by 467
Ling, R., Mutimer, D., Ahmed, M., Boxall, E. H., Elias, E., Dusheiko, G. M., & Harrison, T. J. (1996) · Hepatology · doi:10.1002/hep.510240339 · Cited by 466
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
Boni, C., Bertoletti, A., Penna, A., Cavalli, A., Pilli, M., Urbani, S., Scognamiglio, P., Boehme, R., Panebianco, R., Fiaccadori, F., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3731 · Cited by 459
Lau, G. K. K., Yiu, H. H. Y., Fong, D. Y. T., Cheng, H.-C., Au, W.-Y., Lai, L. S. F., Cheung, M., Zhang, H.-Y., Lie, A., Ngan, R., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.026 · Cited by 458
Hui, C., Cheung, W. W. W., Zhang, H., Au, W., Yueng, Y., Leung, A. Y. H., Leung, N., Luk, J. M., Lie, A. K. W., Kwong, Y., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.015 · Cited by 453
LAI, C., LEUNG, N., TEO, E., TONG, M., WONG, F., HANN, H., HAN, S., POYNARD, T., MYERS, M., & CHAO, G. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.053 · Cited by 449
Soriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
Lok, A. S. F. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205303462202 · Cited by 442
Self-citationGuidotti, L. G., Ando, K., Hobbs, M. V., Ishikawa, T., Runkel, L., Schreiber, R. D., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3764 · Cited by 412
Magnius, L. O., & Norder, H. (1995) · Intervirology · doi:10.1159/000150411 · Cited by 400
Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy
Hoofnagle, J. H., Dusheiko, G. M., Schafer, D. F., Jones, E. A., Micetich, K. C., Young, R. C., & Costa, J. C. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-447 · Cited by 396
Self-citationvan Bömmel, F., Wünsche, T., Mauss, S., Reinke, P., Bergk, A., Schürmann, D., Wiedenmann, B., & Berg, T. (2004) · Hepatology · doi:10.1002/hep.20464 · Cited by 389
Long-term therapy of chronic hepatitis B with lamivudine
Lau, D. T.-Y., Khokhar, F. M., Doo, E., Ghany, M. G., Herion, D., Park, Y., Kleiner, D. E., Schmid, P., Condreay, L. D., Gauthier, J., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.17912 · Cited by 348
Self-citationLiaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors
Wachs, M. E., Amend, W. J., Ascher, N. L., Bretan, P. N., Emond, J., Lake, J. R., Melzer, J. S., Roberts, J. P., Tomlanovich, S. J., Vincenti, F., et al. (1995) · Transplantation · doi:10.1097/00007890-199501000-00014 · Cited by 338
Song, B.-C., Suh, D. J., Lee, H. C., Chung, Y.-H., & Lee, Y. S. (2000) · Hepatology · doi:10.1053/jhep.2000.16665 · Cited by 336
The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors
Wachs, M. E., Amend, W. J., Ascher, N. L., Bretan, P. N., Emond, J., Lake, J. R., Melzer, J. S., Roberts, J. P., Tomlanovich, S. J., Vincenti, F., et al. (1995) · Transplantation · doi:10.1097/00007890-199501270-00014 · Cited by 333
From Hepatitis to Hepatoma: Lessons from Type B Viral Hepatitis
Chen, D.-S. (1993) · Science · doi:10.1126/science.8211155 · Cited by 325
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B
van Zonneveld, M., Honkoop, P., Hansen, B. E., Niesters, H. G. M., Murad, S. D., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20128 · Cited by 322
Clinical Trial of Lamivudine in Children with Chronic Hepatitis B
Jonas, M. M., Kelley, D. A., Mizerski, J., Badia, I. B., Areias, J. A., Schwarz, K. B., Little, N. R., Greensmith, M. J., Gardner, S. D., Bell, M. S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012452 · Cited by 309
The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers
de Franchis, R., Meucci, G., Vecchi, M., Tatarella, M., Colombo, M., Del Ninno, E., Rumi, M. G., Donato, M. F., & Ronchi, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00006 · Cited by 292
van Zonneveld, M., van Nunen, A. B., Niesters, H. G. M., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00440.x · Cited by 289
Spontaneous reactivation of chronic hepatitis B virus infection
Davis, G. L., Hoofnagle, J. H., & Waggoner, J. G. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90406-2 · Cited by 288
Self-citationvan Bömmel, F., Zöllner, B., Sarrazin, C., Spengler, U., Hüppe, D., Möller, B., Feucht, H.-H., Wiedenmann, B., & Berg, T. (2006) · Hepatology · doi:10.1002/hep.21253 · Cited by 287
Tsai, S. L., Chen, P. J., Lai, M. Y., Yang, P. M., Sung, J. L., Huang, J. H., Hwang, L. H., Chang, T. H., & Chen, D. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115590 · Cited by 287
Lampertico, P., Viganò, M., Manenti, E., Iavarone, M., Lunghi, G., & Colombo, M. (2005) · Hepatology · doi:10.1002/hep.20939 · Cited by 272
Survival in patients with HIV infection and viral hepatitis B or C: a cohort study
Bonacini, M., Louie, S., Bzowej, N., & Wohl, A. R. (2004) · AIDS · doi:10.1097/00002030-200410210-00008 · Cited by 264
Fontana, R. J., Hann, H.-W. L., Perrillo, R. P., Vierling, J. M., Wright, T., Rakela, J., Anschuetz, G., Davis, R., Gardner, S. D., & Brown, N. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.35352 · Cited by 264
Flink, H. J., van Zonneveld, M., Hansen, B. E., de Man, R. A., Schalm, S. W., Janssen, H. L. A., & for the HBV 99-01 Study Group* (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00418.x · Cited by 262
Sokal, E. M., Conjeevaram, H. S., Roberts, E. A., Álvarez, F., Bern, E. M., Goyens, P. J., Rosenthal, P. J., Lachaux, A., Shelton, M., & Sarles, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70318-x · Cited by 260
Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years
Manno, M., Cammà, C., Schepis, F., Bassi, F., Gelmini, R., Giannini, F., Miselli, F., Grottola, A., Ferretti, I., Vecchi, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.021 · Cited by 256
Dore, G. J., Cooper, D. A., Pozniak, A. L., DeJesus, E., Zhong, L., Miller, M. D., Lu, B., Cheng, A. K., & Teams, T. 9. A. 9. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/380398 · Cited by 253
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
Yim, H. J., Hussain, M., Liu, Y., Wong, S. N., Fung, S. K., & Lok, A. S. F. (2006) · Hepatology · doi:10.1002/hep.21290 · Cited by 253
Self-citationBortolotti, F., Guido, M., Bartolacci, S., Cadrobbi, P., Crivellaro, C., Noventa, F., Morsica, G., Moriondo, M., & Gatta, A. (2006) · Hepatology · doi:10.1002/hep.21077 · Cited by 237
Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study
Puoti, M., Spinetti, A., Ghezzi, A., Donato, F., Zaltron, S., Putzolu, V., Quiros-Roldan, E., Zanini, B., Casari, S., & Carosi, G. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200007010-00003 · Cited by 224
Ostuni, P., Botsios, C., Punzi, L., Sfriso, P., & Todesco, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.686 · Cited by 217
Hepatocyte turnover during resolution of a transient hepadnaviral infection
Summers, J., Jilbert, A. R., Yang, W., Aldrich, C. E., Saputelli, J., Litwin, S., Toll, E., & Mason, W. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635109100 · Cited by 211
Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion
Tanji, N., Tanji, K., Kambham, N., Markowitz, G. S., Bell, A., & D'Agati, V. D. (2001) · Human Pathology · doi:10.1053/hupa.2001.25586 · Cited by 207
Natural history of hepatitis B: Epidemiology
(2010) · Hepatitis C and B · doi:10.4324/9780203357187_chapter_17 · Cited by 204
Natural history of hepatitis B
Fattovich, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00139-9 · Cited by 199
Chu, C. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02097.x · Cited by 199
Yao, F. Y., & Bass, N. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80371-2 · Cited by 182
Peters, M. G., Andersen, J., Lynch, P., Liu, T., Alston-Smith, B., Brosgart, C. L., Jacobson, J. M., Johnson, V. A., Pollard, R. B., Rooney, J. F., et al. (2006) · Hepatology · doi:10.1002/hep.21388 · Cited by 180
Guañabens, N., Parés, A., Ros, I., Caballería, L., Pons, F., Vidal, S., Monegal, A., Peris, P., & Rodés, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.035 · Cited by 179
Dh??din, N., Douvin, C., Kuentz, M., Saint Marc, M. F., Reman, O., Rieux, C., Bernaudin, F., Norol, F., Cordonnier, C., Bobin, D., et al. (1998) · Transplantation · doi:10.1097/00007890-199809150-00012 · Cited by 174
Renal safety of tenofovir in HIV treatment-experienced patients
Izzedine, H., Isnard-Bagnis, C., Hulot, J. S., Vittecoq, D., Cheng, A., Jais, C. K., Launay-Vacher, V., & Deray, G. (2004) · AIDS · doi:10.1097/00002030-200404300-00019 · Cited by 173
Gallant, J. E., & Deresinski, S. (2003) · Clinical Infectious Diseases · doi:10.1086/378068 · Cited by 162
Izzedine, H., Hulot, J. S., Launay-Vacher, V., Marcellini, P., Hadziyannis, S. J., Currie, G., Brosgart, C. L., Westland, C., Arterbrun, S., & Deray, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00866.x · Cited by 159
Native Hepatitis B Virions and Capsids Visualized by Electron Cryomicroscopy
Dryden, K. A., Wieland, S. F., Whitten-Bauer, C., Gerin, J. L., Chisari, F. V., & Yeager, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.025 · Cited by 159
Coca, S. G., & Perazella, M. A. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200212000-00011 · Cited by 154
(2006) · PEDIATRICS · doi:10.1542/peds.2006-1181 · Cited by 147
King, R. W., Ladner, S. K., Miller, T. J., Zaifert, K., Perni, R. B., Conway, S. C., & Otto, M. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3179 · Cited by 144
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
Sokal, E. M., Kelly, D. A., Mizerski, J., Badia, I. B., Areias, J., Schwarz, K. B., Vegnente, A., Little, N. R., Gardener, S. D., & Jonas, M. M. (2006) · Hepatology · doi:10.1002/hep.21020 · Cited by 140
Liver Biopsy Size Matters in Chronic Hepatitis: Bigger Is Better
Scheuer, P. J. (2003) · Hepatology · doi:10.1016/j.hep.2003.10.010 · Cited by 123
Liang, J. T., Blum, H. E., & Wands, J. R. (1990) · Hepatology · doi:10.1002/hep.1840120205 · Cited by 123
Kohrt, H. E. K., Ouyang, D. L., & Keeffe, E. B. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03081.x · Cited by 123
Hepatitis B virus infection in patients with idiopathic liver disease
Liang, J. T., Baruch, Y., Ben‐Porath, E., Enat, R., Bassan, L., Brown, N. V., Rimon, N., Blum, H. E., & Wands, J. R. (1991) · Hepatology · doi:10.1002/hep.1840130607 · Cited by 120
Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice
Guidotti, L. G., Morris, A., Mendez, H., Koch, R. J., Silverman, R. H., Williams, B. R. G., & Chisari, F. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2617-2621.2002 · Cited by 119
Parsonage, M., Wilkins, E. G., Snowden, N., Issa, B. G., & Savage, M. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00318.x · Cited by 115
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure
Rifkin, B. S., & Perazella, M. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.025 · Cited by 114
Dyson, M. R., & Murray, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2194 · Cited by 110
Blanpain, C., Knoop, C., Delforge, M., Antoine, M., Peny, M.-O., Liesnard, C., Vereerstraeten, P., Cogan, E., Adler, M., & Abramowicz, D. (1998) · Transplantation · doi:10.1097/00007890-199810150-00012 · Cited by 108
Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy
Su, G.-G., Pan, K.-H., Zhao, N.-F., Fang, S.-H., Yang, D.-H., & Zhou, Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i6.910 · Cited by 90
Lamivudine treatment for acute severe hepatitis B: a pilot study
Schmilovitz‐Weiss, H., Ben‐Ari, Z., Sikuler, E., Zuckerman, E., Sbeit, W., Ackerman, Z., Safadi, R., Lurie, Y., Rosner, G., Tur‐Kaspa, R., et al. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0983.x · Cited by 85
The use of lamivudine for patients with acute hepatitis B (a series of cases)
Kondili, L. A., Osman, H. K. E., & Mutimer, D. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00504.x · Cited by 48
Lopez, V. A., Bourne, E. J., Lutz, M. W., & Condreay, L. D. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.1972-1976.2002 · Cited by 40
Lampertico, P., Marzano, A., Levrero, M., Santantonio, T. A., Andreoné, P., Brunetto, M. R., Marco, V. D., FAGIUOLI, S., Mazzella, G., & Raimondo, G. (2006) · Journal of Hepatology · doi:10.1016/s0168-8278(06)80117-0 · Cited by 19
Xiao, J.-B., Zhang, L., Chen, X.-Q., Xu, M., & Jiang, X.-Y. (2007) · The Professional Medical Journal · doi:10.29309/tpmj/2007.14.02.4883
Cited by
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Self-citationEASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationEASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
Liaw, Y.-F., & Chu, C.-M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60207-5 · Cited by 1,218
Metadata
- Authors
- Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F.
- Venue
- Hepatology
- Published
- 2007-04
- Volume
- 45
- Issue
- 4
- Pages
- 1056-1075
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2071337588
- Cited by
- 628
- References
- 115
- FWCI
- 48.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.